Metabolic Safety: IGF-1 and Glucose Effects One of the most clinically significant safety findings relates to AOD-9604s metabolic profile, particularly its lack of effects on insulin-like growth factor-1 (IGF-1) and glucose metabolism
For active weight management: weekly or bi-weekly Skinny Shots, transitioning to monthly for maintenance
Professional athletes or regular people with post-workout injuries Aged people with wear and tear damage to the tendon, ligament, muscle, and bone Patients with gastrointestinal diseases, like gastric ulcers, leaky gut, irritable bowel syndrome, and Crohns disease More applications for BPC-157 are under investigation
For researchers seeking a replacement, PSPeptides has published a comprehensive Peptide Sciences Alternative guide and a Best Peptide Companies 2026 evaluation
However, optimal results typically develop gradually throughout 4 to 6 weeks as the body processes the nutrients and supports fat burning